Wedmont Private Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.62M | Buy |
39,996
+2,751
| +7% | +$524K | 0.33% | 44 |
|
|
2025
Q1 | $6.52M | Buy |
37,245
+11,423
| +44% | +$2M | 0.33% | 46 |
|
|
2024
Q4 | $4.52M | Buy |
25,822
+3,654
| +16% | +$640K | 0.24% | 60 |
|
|
2024
Q3 | $4.29M | Buy |
22,168
+1,051
| +5% | +$203K | 0.25% | 57 |
|
|
2024
Q2 | $3.6M | Buy |
21,117
+2,621
| +14% | +$446K | 0.23% | 63 |
|
|
2024
Q1 | $3.15M | Buy |
18,496
+851
| +5% | +$145K | 0.23% | 61 |
|
|
2023
Q4 | $2.85M | Buy |
17,645
+899
| +5% | +$145K | 0.23% | 62 |
|
|
2023
Q3 | $2.5M | Buy |
16,746
+4,615
| +38% | +$688K | 0.25% | 64 |
|
|
2023
Q2 | $1.65M | Sell |
12,131
-5,576
| -31% | -$758K | 0.18% | 82 |
|
|
2023
Q1 | $2.86M | Buy |
17,707
+484
| +3% | +$78.1K | 0.38% | 46 |
|
|
2022
Q4 | $2.87M | Buy |
17,223
+2,723
| +19% | +$454K | 0.43% | 42 |
|
|
2022
Q3 | $1.95M | Buy |
14,500
+3,003
| +26% | +$403K | 0.39% | 39 |
|
|
2022
Q2 | $1.76M | Buy |
11,497
+356
| +3% | +$54.5K | 0.38% | 45 |
|
|
2022
Q1 | $1.8M | Buy |
11,141
+1,704
| +18% | +$276K | 0.4% | 41 |
|
|
2021
Q4 | $1.26M | Buy |
+9,437
| New | +$1.26M | 0.39% | 47 |
|